Sun Pharma eyes tie-ups in Europe

-

Sun Pharma eyes tie-ups in Europe


DRUG major Sun Pharmaceuticals Industries Ltd is looking for partnerships in the European market to fuel its next level of growth in the international arena. 


The company, however, has dropped its plans to raise funds of about $350 million through a foreign currency convertible bond issue. To support the company's domestic and export plans, an investment of about Rs 100 crore has been earmarked towards beefing up capacity. 


A bulk of the amount would go into capacity expansion at Sun Pharma's facilities in Panoli and Ahmednagar, part of it would also go towards Sun's Halol plant, that had received US regulatory approval in the quarter under review. 


An estimated Rs 15 crore would be infused into the cephalosporin bulk active plant that comes into the Sun fold, through its merger with Phlox Pharma. Part of the funds would also go towards upgrading machinery in other facilities belonging to Sun Pharma, officials said.

Comments

Post a Comment

Popular posts from this blog

 Role of Blockchain in Healthcare Data Management

-
Image
ROLE OF BLOCKCHAIN IN HEALTHCARE DATA MANAGEMENT I n recent years, the healthcare industry has been undergoing a digital transformation, leveraging innovative technologies to improve patient care and data management.   One such technology that has gained significant attention is blockchain. Originally known for powering cryptocurrencies like Bitcoin, blockchain has found a remarkable application in healthcare data management.  This decentralized and secure ledger system holds immense potential to revolutionize the way sensitive medical information is stored, shared, and utilized across the healthcare ecosystem.  What is  Role of Blockchain in Healthcare Data Management? Blockchain technology has the potential to  revolutionize healthcare data management. It is a type of distributed ledger technology (DLT)  that leverages decentralized peer-to-peer computing, cryptography, and related technology to verify and propagate a chain of transaction records across a consortium, alliance, part
Read more

Demystifying AI in Drug Discovery: Transforming Pharma R&D

-
Image
Demystifying AI in Drug Discovery: Transforming Pharma R&D Artificial Intelligence (AI) has swiftly transformed industries, and drug discovery is no exception.  The pharmaceutical research and development (R&D) process has traditionally been lengthy, resource-intensive, and marked by high failure rates. However, with the advent of AI, a new era has dawned, promising to revolutionize the drug discovery landscape.  This article delves into the nuances of AI in drug discovery , exploring how it's reshaping pharma R&D processes and accelerating the journey toward innovative therapies. 1. Understanding AI in Drug Discovery: AI refers to the simulation of human intelligence in machines, enabling them to perform tasks that typically require human cognition, such as learning, reasoning, and problem-solving.  In drug discovery, AI algorithms analyze vast datasets to identify patterns, predict outcomes, and generate insights that aid in the identification and development of poten
Read more